| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Biomedical Research Institute, Children's Hospital, 345 N. Smith Avenue, St Paul, Minnesota 55102, U.S.A.
The structure and heparin binding properties of a family of human cytomegalovirus (HCMV) disulphide-linked glycoprotein complexes designated gC-II were analysed. gC-II complexes contain two groups of glycoproteins designated Group 1 and Group 2. These glycoproteins were separated from each other by short exposure of virions to a reducing agent. This showed that the disulphide bonds between these glycoproteins were on the external surface of the virion. Although these glycoproteins were no longer associated they were not released from the virion, suggesting that they were transmembrane glycoproteins. Approximately 75 to 90% of the gC-II complexes and 18% of the complexes containing the HCMV gB glycoprotein obtained from the virion envelope bound immobilized heparin. When virions were incubated with [3H]heparin, gC-II complexes bound more heparin than gB complexes, by approximately threefold. These data showed that gC-II complexes had a greater heparin-binding capacity. After treatment of virions with a reducing agent the affinity of gC-II glycoproteins for heparin was greatly reduced whereas the affinity of gB glycoproteins was only slightly reduced. Thus, higher order structure was important for heparin binding by gC-II complexes but not by those of gB. Relative to gC-II Group 1 glycoproteins, a greater portion of gC-II Group 2 glycoproteins still bound to heparin after reduction, suggesting that Group 2 glycoproteins may be the important heparin binding component of the gC-II complexes. Both gB and gC-II complexes were eluted from immobilized heparin with soluble heparin or 0·65 M-NaCl suggesting that both formed ionic bonds with heparin. Chondroitin sulphate was not effective at eluting HCMV envelope glycoproteins from immobilized heparin. Thus, the structure of the glucosaminoglycan backbone is important to the binding of HCMV glycoproteins to heparin.
Received 11 May 1992;
accepted 1 October 1992.
This article has been cited by other articles:
|
|
 |
|
  M. Krzyzaniak, M. Mach, and W. J. Britt The Cytoplasmic Tail of Glycoprotein M (gpUL100) Expresses Trafficking Signals Required for Human Cytomegalovirus Assembly and Replication J. Virol., October 1, 2007; 81(19): 10316 - 10328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Derry, M. R. Sutherland, C. M. Restall, D. M. Waisman, and E. L. G. Pryzdial Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5 J. Gen. Virol., January 1, 2007; 88(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shimamura, M. Mach, and W. J. Britt Human Cytomegalovirus Infection Elicits a Glycoprotein M (gM)/gN-Specific Virus-Neutralizing Antibody Response J. Virol., May 1, 2006; 80(9): 4591 - 4600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lopper and T. Compton Coiled-Coil Domains in Glycoproteins B and H Are Involved in Human Cytomegalovirus Membrane Fusion J. Virol., August 1, 2004; 78(15): 8333 - 8341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Netterwald, T. R. Jones, W. J. Britt, S.-J. Yang, I. P. McCrone, and H. Zhu Postattachment Events Associated with Viral Entry Are Necessary for Induction of Interferon-Stimulated Genes by Human Cytomegalovirus J. Virol., June 15, 2004; 78(12): 6688 - 6691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Jones, S.-W. Lee, S. V. Johann, V. Razinkov, R. J. Visalli, B. Feld, J. D. Bloom, and J. O'Connell Specific Inhibition of Human Cytomegalovirus Glycoprotein B-Mediated Fusion by a Novel Thiourea Small Molecule J. Virol., February 1, 2004; 78(3): 1289 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gicklhorn, M. Eickmann, G. Meyer, M. Ohlin, and K. Radsak Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion J. Gen. Virol., July 1, 2003; 84(7): 1859 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lopper and T. Compton Disulfide Bond Configuration of Human Cytomegalovirus Glycoprotein B J. Virol., May 13, 2002; 76(12): 6073 - 6082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mach, B. Kropff, P. Dal Monte, and W. Britt Complex Formation by Human Cytomegalovirus Glycoproteins M (gpUL100) and N (gpUL73) J. Virol., December 15, 2000; 74(24): 11881 - 11892. [Abstract] [Full Text]
|
|
|
|
|
|
D. Skrincosky, P. Hocknell, L. Whetter, P. Secchiero, B. Chandran, and S. Dewhurst Identification and Analysis of a Novel Heparin-Binding Glycoprotein Encoded by Human Herpesvirus 7 J. Virol., May 15, 2000; 74(10): 4530 - 4540. [Abstract] [Full Text]
|
|
|
|
|
|
B. T. Ober, B. Teufel, K.-H. Wiesmüller, G. Jung, E. Pfaff, A. Saalmüller, and H.-J. Rziha The Porcine Humoral Immune Response against Pseudorabies Virus Specifically Targets Attachment Sites on Glycoprotein gC J. Virol., February 15, 2000; 74(4): 1752 - 1760. [Abstract] [Full Text]
|
|
|
|
|
|
A. Mirazimi, M. Mousavi-Jazi, V.-A. Sundqvist, and L. Svensson Free thiol groups are essential for infectivity of human cytomegalovirus J. Gen. Virol., November 1, 1999; 80(11): 2861 - 2865. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. Boyle and T. Compton Receptor-Binding Properties of a Soluble Form of Human Cytomegalovirus Glycoprotein B J. Virol., March 1, 1998; 72(3): 1826 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Trybala, T. Bergstrom, D. Spillmann, B. Svennerholm, S. J. Flynn, and P. Ryan Interaction between Pseudorabies Virus and Heparin/Heparan Sulfate. PSEUDORABIES VIRUS MUTANTS DIFFER IN THEIR INTERACTION WITH HEPARIN/HEPARAN SULFATE WHEN ALTERED FOR SPECIFIC GLYCOPROTEIN C HEPARIN-BINDING DOMAIN J. Biol. Chem., February 27, 1998; 273(9): 5047 - 5052. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
